Paid Clinical Trials in Chula Vista, CA
As of June 2026, 51 paid clinical trials are recruiting in Chula Vista, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Chula Vista offers studies at sites including California Institute of Renal Research for conditions such as Heart Failure, Coronary Artery Disease, Diabetes Mellitus, Type 2, Hypertension. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Chula Vista
Trials by drug in Chula Vista
Filter results
51 clinical trials
↓ Download CSVA Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers
A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Supraglottic Airway for Resuscitation Trial
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Surfactant Using a Supraglottic Airway Device in Late Preterm to Early Term Infants
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
A Study of RSLV-132 in Females With Sjögren's Disease
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Continuation Protocol for Obstructive Sleep Apnea (OSA)
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
About research studies in Chula Vista
Chula Vista has approximately 51 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in Chula Vista
Researchers run research studies in Chula Vista, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| California Institute of Renal Research | Atherosclerotic Cardiovascular Disease in Patients With ESKD, CKD, Chronic Kidney Disease Requiring Chronic Dialysis | 3 |
| Velocity Clinical Research-Chula Vista | Heart Failure, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis | 3 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 2 |
| Exalt Clinical Research | Obstructive Sleep Apnea (OSA), Plaque Psoriasis | 2 |
| Pain Consultants of San Diego | Chronic Pain, Lumbar Spinal Stenosis | 2 |
| ProSciento, Inc. | Healthy, Type 1 Diabetes | 2 |
| Sharp Chula Vista Medical Center | Delivery Room Resuscitation, Implementation Research, Infant, Newborn | 2 |
| Advanced Clinical Research Center, LLC dba TriWest Research Associates | Rheumatoid Arthritis | 1 |
| Akero Clinical Study Site | MASH With Fibrosis, NASH With Fibrosis | 1 |
| Amphastar Study Site | Insulin Aspart, Pharmacodynamics, Pharmacokinetics | 1 |
| Artiva Investigational Site Chula Vista | IIM, Idiopathic Inflammatory Myopathies (IIMs), Myositis | 1 |
| CISD Sharp Chula Vista | Coronary Artery Disease | 1 |
| Cardiovascular Institute of San Diego | Diabetes Mellitus, Type 2, Metabolic Syndrome, PreDiabetes | 1 |
| Chula Vista, CA Investigative | Acute Heart Failure, Heart Failure | 1 |
| Erick Alayo Medical Corp/Gastro SB Clinic | Ulcerative Colitis, Ulcerative Colitis Chronic | 1 |
| Erick H. Alayo Medical Corporation | Chronic Idiopathic Constipation (CIC) | 1 |
| Exalt Clinical Research, Inc. | OSA | 1 |
| GW Research Inc. | Chronic Idiopathic Constipation (CIC) | 1 |
| GW Research, Inc | Eosinophilic Esophagitis | 1 |
| GastroSb Weight Loss Clinic | Ulcerative Colitis | 1 |
| Investigator | Focal Segmental Glomerulosclerosis | 1 |
| Jade Clinical Site | IgA Nephropathy | 1 |
| Marea | Hypertriglyceridemia | 1 |
| Northgate Gonzalez Market | Healthy Subjects, Memory Decline | 1 |
| Precision Recearch Institute | Advanced Adenomas (AA), Colorectal Cancer (CRC) | 1 |
Active & Upcoming Studies in Chula Vista (2026)
Recruiting trials in Chula Vista grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (8 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500 · Phase 1 · Portal Diabetes, Inc.
Cardiovascular (8 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Neurology & pain (2 active studies)
- DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea. · Phase 2 · Incannex Healthcare Ltd
- Patient Retrospective Outcomes (PRO) · Boston Scientific Corporation
Pediatric (2 active studies)
- Supraglottic Airway for Resuscitation Trial · Children's Hospital of Philadelphia
- Surfactant Using a Supraglottic Airway Device in Late Preterm to Early Term Infants · Sharp HealthCare
Cancer & tumors (1 active study)
- Collection of Samples USOPTIVAL Study · Universal Diagnostics
Common conditions studied in Chula Vista
- Heart Failure (4 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Coronary Artery Disease (2 active studies). Coronary artery disease research evaluates lipid-lowering therapies, anti-inflammatory agents, and new revascularization devices.
- Diabetes Mellitus, Type 2 (2 active studies). Diabetes trials evaluate new insulin formulations, GLP-1 receptor agonists, continuous glucose monitoring technologies, and disease-modifying therapies.
- Hypertension (2 active studies). Hypertension research tests new antihypertensive drug classes, renal denervation devices, and fixed-dose combinations for resistant disease.
- Ulcerative Colitis (2 active studies). Ulcerative colitis trials examine biologic therapies, S1P receptor modulators, and oral small molecules for steroid-sparing remission.
- Acute Heart Failure (1 active study). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
Leading research sponsors in Chula Vista
- AstraZeneca
- Boehringer Ingelheim
- Alnylam Pharmaceuticals
- Medtronic
- Merck Sharp & Dohme LLC
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Chula Vista. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Chula Vista
Hipa.ai aggregates every recruiting study in Chula Vista from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Chula Vista?
There are approximately 51 recruiting clinical trials in Chula Vista, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Chula Vista pay participants?
Most recruiting trials in Chula Vista compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Chula Vista?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Chula Vista?
The most common conditions under active study in Chula Vista include Heart Failure (4), Coronary Artery Disease (2), Diabetes Mellitus, Type 2 (2), Hypertension (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Chula Vista?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Chula Vista on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Chula Vista?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Chula Vista?
Recruiting research sites in Chula Vista include California Institute of Renal Research, Velocity Clinical Research-Chula Vista, Clinical Trial Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Chula Vista right now?
The largest active categories in Chula Vista are Diabetes & metabolic (8), Cardiovascular (8), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.